New data shows hospital security guards are getting injured at an alarming rate
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
17 minutes ago
- Globe and Mail
SelectQuote to Release Fiscal Fourth Quarter and Full Year 2025 Earnings on August 21
SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly growing Healthcare Services platform, today announced it will release its fourth quarter and full year 2025 financial results before market open on Thursday, August 21, 2025. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (August 21, 2025) at 8:30 am ET to discuss the results. To register for this conference call, please use this link: After registering, a confirmation will be sent via email, including dial in details and unique conference call codes for entry. Registration is open through the live call, but to ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call. The event will also be webcasted live via our investor relations website or via this link. About SelectQuote: Founded in 1985, SelectQuote (NYSE: SLQT) pioneered the model of providing unbiased comparisons from multiple, highly-rated insurance companies, allowing consumers to choose the policy and terms that best meet their unique needs. Two foundational pillars underpin SelectQuote's success: a strong force of highly-trained and skilled agents who provide a consultative needs analysis for every consumer, and proprietary technology that sources and routes high-quality leads. Today, the Company operates an ecosystem offering high touchpoints for consumers across insurance, pharmacy, and virtual care. With an ecosystem offering engagement points for consumers across insurance, Medicare, pharmacy, and value-based care, the company now has three core business lines: SelectQuote Senior, SelectQuote Healthcare Services, and SelectQuote Life. SelectQuote Senior serves the needs of a demographic that sees around 10,000 people turn 65 each day with a range of Medicare Advantage and Medicare Supplement plans. SelectQuote Healthcare Services is comprised of the SelectRx Pharmacy, a Patient-Centered Pharmacy Home™ (PCPH) accredited pharmacy, SelectPatient Management, a provider of chronic care management services, and Healthcare Select, which proactively connects consumers with a wide breadth of healthcare services supporting their needs.
National Post
17 minutes ago
- National Post
NEUPATH HEALTH TO REPORT Q2 RESULTS AND HOST INVESTOR WEBINAR
Article content NeuPath to report Q2 2025 results on August 14 th before markets open Article content TORONTO — NeuPath Health Inc. (TSXV:NPTH), ('NeuPath' or the 'Company'), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced that it will release its financial results for the second quarter of 2025 before market open on Thursday, August 14, 2025. Investors and stakeholders are invited to join a live webinar with Joe Walewicz, Chief Executive Officer of NeuPath, for a detailed presentation and discussion of the Company's results, operations and strategic outlook. Article content Article content Event: Article content Presentation and Q&A Webinar with NeuPath Health Inc. (NPTH) Article content Article content Host: Article content Martin Gagel, Radius Research Article content Article content Presentation Date & Time: Article content Thursday, August 21, 2025 at 10:00 AM ET / 7:00 AM PT Article content Article content Webcast Registration Link: Article content Market Radius Research gives individual investors access to in-depth CEO interviews with deep-dive institutional level discussion and Q&A. Market Radius is hosted by Martin Gagel, former top-ranked technology analyst. By registering for this webinar, you agree to receive email communications from Market Radius Capital, Inc. and from the presenting company (with unsubscribe). Your email will not be further shared. Martin Gagel and Market Radius Capital, Inc. are not registered or licensed to provide investment advice and may own shares in mentioned companies and are compensated by the Company for these services. Content is for information purposes only and is not advice or recommendations and may include incomplete or incorrect information. Investing entails a high degree of risk. This is a production of Market Radius Capital, Inc. Article content About NeuPath Health Inc. Article content NeuPath operates a network of healthcare clinics and related businesses focused on improved access to care and outcomes for patients by leveraging best-in-class treatments and delivering patient-centered multidisciplinary care. We operate a network of medical clinics in Ontario and Alberta that provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal/back injuries, sports related injuries and concussions. In addition, NeuPath provides workplace health services and independent medical assessments to employers and disability insurers through a national network of healthcare providers, as well as contract research services to pharmaceutical and biotechnology companies. NeuPath is focused on enabling each individual to live their best life. For additional information, please visit Article content Forward Looking Information: Article content This news release contains forward-looking statements. All statements, other than statements of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future including, without limitation, the Company's expectation of continued operational improvements in 2025 and the execution of the Company's growth opportunities are forward-looking statements. These forward-looking statements reflect the current expectations or beliefs of the Company based on information currently available to the Company. Forward-looking statements are subject to a number of risks and uncertainties that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, the Company. Factors that could cause actual results or events to differ materially from current expectations included in this news release include, among other things, adverse market conditions, risks associated with obtaining and maintaining the necessary governmental permits and licenses related to the business of the Company, increasing competition in the market and other risks generally inherent in the chronic pain, sports medicine, concussion and workplace health services markets. A comprehensive discussion of these and other risks and uncertainties can be found in the Company's Annual Information Form dated March 26, 2025 filed on SEDAR+ under the Company's profile at Article content Article content . Article content Any forward-looking statement speaks only as of the date on which it is made and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or results or otherwise. Although the Company believes that the assumptions underlying the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and accordingly undue reliance should not be put on such statements due to their inherent uncertainty. Article content Article content Article content Article content Article content Contacts Article content For further information, please contact: Article content Article content Article content
National Post
2 hours ago
- National Post
EXCLUSIVE: Puppies secretly tested and killed at Ontario hospital for human heart research
Article content Some experts are skeptical. Article content 'Dogs are not 50-pound humans,' said Dr. John Pippin, a cardiovascular surgeon who previously performed heart attack research on dogs and now advocates for animal-free research as the director of academic affairs at the Physicians Committee for Responsible Medicine. Article content 'They have distinctly different anatomy. They have different genetic characteristics that do not translate to humans. You can't do anything to make them transferable to human medicine.' Article content More than 90 per cent of drugs tested on animals never receive approval from the U.S. Food and Drug Administration due to safety and efficacy issues. A 2024 meta analysis of more than 120 academic papers on the subject found just five per cent of therapies tested in animals end up as human drugs. Canada does not publish comparable figures. Article content Internationally, researchers are conducting cardiac research with healthy human volunteers or patients undergoing cardiac treatments, said Charu Chandrasekera, founder of the Canadian Centre for Alternatives to Animal Methods and an international expert in animal-free science. Article content Article content 'While clinically relevant studies were being published, tracking how human hearts recover after a heart attack, researchers in Canada were busy filling out forms to order more dogs. The goal should be to expand human data, not invent new dog experiments.' Article content The written statement from St. Joseph's said effective alternatives to dog testing 'don't yet exist for this specific line of inquiry,' and that 'these techniques are essential for providing clinical teams with tools that permit proper diagnosis and treatment for one of the leading causes of death in Canada.' Article content Frank Prato, the founder of the Lawson Imaging Research Program and lead researcher of the studies, has a long history of academic publications involving dog research dating back to at least 1983. Prato has been sacrificing dogs in his studies since at least 1985, according to a dog lung study published that year. Article content His biography on the St. Joseph's website does not reference dog testing of any kind. It reads: 'Over the last 30 years I have founded a research imaging program at Lawson…The focus is to provide leading edge medical imaging technology to the patients of Southwestern Ontario.' Article content Article content Since 2020, Prato has received nearly $500,000 in grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) to perform these studies at Lawson. NSERC grants are publicly funded through federal tax dollars. Article content A written statement from St. Joseph's says the number of 'adult' dogs killed annually is 15. Asked to explain the discrepancy, the hospital says it has improved 'processes' that resulted in using fewer animals. Article content Article content The IJB asked the hospital for the total number of dogs of all ages that were killed as part of research at the lab over the past five years. It declined to provide an answer. Article content 'We appreciate the importance of transparency and are working in alignment with regulatory bodies and partners to follow their protocols in this regard,' the response said.
